Antisense oligonucleotide modulation of STAT3 expression

Details for Australian Patent Application No. 2004316504 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Karras, James G.

Agent Spruson & Ferguson

Pub. Number AU-B-2004316504

PCT Pub. Number WO2005/083124

Priority 10/773,678 06.02.04 US

Filing date 30 September 2004

Wipo publication date 9 September 2005

Acceptance publication date 9 December 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/083124 Priority application(s): WO2005/083124

9 December 2010 Application Accepted

  Published as AU-B-2004316504

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004316521-Self-drilling anchor

2004316497-Transmission and constant speed accessory drive